Timing of Antihypertensive Medications and Cardiovascular Outcomes—Reply

In Reply In the recently published BedMed trial,1 we reported that bedtime (vs morning) use of antihypertensive medications was safe but provided no reduction in a composite of death or adverse cardiovascular events.

Authors

Michael R. Kolber (ORCID: https://orcid.org/0000-0001-7490-4633)
Scott Garrison (ORCID: https://orcid.org/0000-0002-7024-2158)
Christina Korownyk (ORCID: https://orcid.org/0000-0003-4953-9392)

Institutions

University of Alberta (CA)

Publication Details

Journal: JAMA
Published: 2025-09-17
DOI: https://doi.org/10.1001/jama.2025.12796
Primary Topic: Blood Pressure and Hypertension Studies
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Timing of Antihypertensive Medications and Cardiovascular Outcomes—Reply

Michael R. Kolber, Scott Garrison, Christina Korownyk

Sep 17, 2025

JAMA

Blood Pressure and Hypertension Studies

article

Timing of Antihypertensive Medications and Cardiovascular Outcomes—Reply

Michael R. Kolber, Scott Garrison, Christina Korownyk

September 17, 2025article en

Abstract

JAMAVol. 334(16)

University of Alberta (CA)

Openalex Percentile: Top 61%

Blood Pressure and Hypertension Studies

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Timing of Antihypertensive Medications and Cardiovascular Outcomes—Reply — Michael R. Kolber, Scott Garrison, et al. · JAMA (2025) | TGRS Research Map | TGRS